UBS Group AG - TREVI THERAPEUTICS INC ownership

TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 24 filers reported holding TREVI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TREVI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$49,214
-14.4%
22,575
-6.2%
0.00%
Q2 2023$57,491
+310.0%
24,055
+217.3%
0.00%
Q1 2023$14,023
+135.0%
7,580
+145.2%
0.00%
Q4 2022$5,966
-14.8%
3,091
-27.7%
0.00%
Q3 2022$7,000
-46.2%
4,277
-10.4%
0.00%
Q2 2022$13,000
+225.0%
4,771
+193.8%
0.00%
Q1 2022$4,000
-42.9%
1,624
-68.6%
0.00%
Q3 2021$7,000
+40.0%
5,173
+142.1%
0.00%
Q2 2021$5,000
-16.7%
2,137
-10.1%
0.00%
Q1 2021$6,000
+200.0%
2,378
+339.6%
0.00%
Q1 2020$2,000
-71.4%
541
-65.7%
0.00%
Q3 2019$7,000
-50.0%
1,577
-17.9%
0.00%
Q2 2019$14,0001,9210.00%
Other shareholders
TREVI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Omega Fund Management, LLC 1,263,408$2,843,0000.32%
NEA Management Company, LLC 5,940,796$13,367,0000.17%
TPG Group Holdings (SBS) Advisors, Inc. 4,824,883$10,856,0000.08%
WealthTrust Axiom LLC 39,500$88,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 34,600$78,0000.00%
BlackRock Inc. 44,180$99,0000.00%
LPL Financial LLC 10,000$23,0000.00%
Alberta Investment Management Corp 25,000$56,0000.00%
Tower Research Capital LLC (TRC) 4,187$10,0000.00%
Renaissance Technologies 92,600$208,0000.00%
View complete list of TREVI THERAPEUTICS INC shareholders